The efficacy and safety of low-molecular-weight heparin and unfractionated heparin in the treatment of cerebral venous sinus thrombosis
Open Access
- 1 October 2015
- journal article
- research article
- Published by Armed Forces Medical Services in Neurosciences
- Vol. 20 (4) , 357-361
Abstract
To compare the efficacy and safety of low-molecular-weight heparin (LMWH) and unfractionated heparin (UFH) in the treatment of patients with cerebral venous sinus thrombosis (CVST), and to provide an appropriate treatment option in these patients. This is a randomized double blind clinical trial conducted between December 2013 and December 2014. The subjects were selected among patients referred to Neurology Department, Imam Reza Hospital; affiliated to Kermanshah University of Medical Sciences, Kermanshah, Iran. Fifty-two cases of CVST were included in this study and randomly divided into 2 groups. Twenty-six cases received LMWH and the other 26 cases received UFH. The primary outcomes include hospital mortality rate and neurologic deficits as assessed by the National Institutes of Health Stroke Scale (NIHSS). The secondary end point was disability as measured by the Modified Rankin Scale (MRS). We observed the rate of mortality and neurological deficits and disability based on NIHSS, and the MRS did not differ between the 2 groups. The efficacy of LMWH and UFH in reduction of neurologic deficit and functional disability in patients with CVST are similar.Keywords
This publication has 14 references indexed in Scilit:
- Cerebral sinus venous thrombosisJournal of Neurosciences in Rural Practice, 2013
- Cerebral Venous Thrombosis in a Mexican Multicenter Registry of Acute Cerebrovascular Disease: The RENAMEVASC StudyJournal of Stroke and Cerebrovascular Diseases, 2012
- Cerebral Venous ThrombosisCirculation, 2012
- Parenteral AnticoagulantsChest, 2012
- Anticoagulation for cerebral venous sinus thrombosisCochrane Database of Systematic Reviews, 2011
- Safety of Thrombolysis in Acute Ischemic Stroke: A Review of Complications, Risk Factors, and Newer TechnologiesThe Neurohospitalist, 2011
- Unfractionated or Low–Molecular Weight Heparin for the Treatment of Cerebral Venous ThrombosisStroke, 2010
- EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patientsEuropean Journal of Neurology, 2010
- Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism2010
- Reliability of the Modified Rankin ScaleStroke, 2009